Načítá se...
Epidermal growth factor receptor dimerization status determines skin toxicity to HER-kinase targeted therapies
Skin toxicity, a common drug-related adverse event observed in cancer patients treated with epidermal growth factor receptor (EGFR)-directed therapies is rarely seen with therapies targeting HER2. This study reports the significance of the EGFR and HER2 dimerization status in skin with regard to the...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Nature Publishing Group
2006
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2361091/ https://ncbi.nlm.nih.gov/pubmed/16306877 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6602875 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|